SELECT TOP (1000) [Source] ,[Taxon] ,[LowValue] ,[HighValue] ,[LowPCile] ,[HighPCile] FROM [DB_A5D9F7_Lassesen].[dbo].[JasonH]

Chlorobiota Details: NCBI 1090, gram-negative or unknown [phylum]

| "Chlorobi" Garrity and Holt 2001| Chlorobaeota| Chlorobaeota Oren et al. 2015| Chlorobi| Chlorobi Iino et al. 2010| Chlorobiota| Green sulfur bacteria

  1. Sulfur metabolism: Chlorobiota bacteria are capable of anoxygenic photosynthesis, using sulfur compounds as electron donors instead of water. This metabolic capability contributes to sulfur cycling in anaerobic environments, where Chlorobiota bacteria participate in the reduction of sulfide and other sulfur compounds. While sulfur cycling is important for ecosystem functioning, alterations in sulfur metabolism could potentially impact water quality parameters and nutrient cycling in aquatic ecosystems, which may indirectly affect human health through changes in ecosystem services or the availability of resources.

  2. Ecological interactions: Chlorobiota bacteria interact with other organisms in anaerobic environments, including other bacteria, archaea, algae, and higher organisms. These ecological interactions influence nutrient cycling, energy flow, and ecosystem dynamics in sediments, wetlands, and aquatic habitats. While the ecological impacts of Chlorobiota are primarily of interest from an environmental perspective, changes in ecosystem functioning could indirectly affect human well-being, such as through alterations in water quality, biodiversity, or the provision of ecosystem services.

  3. Biotechnological applications: Some Chlorobiota bacteria have been studied for their potential biotechnological applications, particularly in environmental or industrial processes such as wastewater treatment, bioremediation, and bioenergy production. While these applications are primarily focused on engineering or ecological objectives rather than direct human health impacts, they highlight the diverse metabolic capabilities and potential practical uses of Chlorobiota bacteria in engineered or managed ecosystems.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Chlorobiota

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 1.24 1 1140 0 678 176.6 70 255.7 0 450 0 %ile 100 %ile
biomesight 77.16 0 160 30 370 0 1698 285.7 90 720.3 0 410 9 %ile 90.8 %ile
thorne 100 15 373 0 224 75.2 45 75.8 27 107 0 %ile 100 %ile
thryve 8.12 0 0 1 68 0 47 22 19 12.7 7 37 0 %ile 100 %ile
ubiome 0.13 0 26 26 26 26 26 0 %ile 99 %ile

External Reference Ranges for Chlorobiota

Chlorobiota (NCBI 1090) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Thorne (20/80%ile) 32.55 68.16 0.0033 0.0068
Statistic by Lab Source for Chlorobiota
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
Biomesight 82.431 %   0.027 %  0.068 % 2360.0 2863
BiomeSightRdp 75 %   0.019 %  0.026 % 24.0 32
CerbaLab 66.667 %   0.001 %  0 % 2.0 3
custom 8.475 %   0.001 %  0.001 % 5.0 59
es-xenogene 13.793 %   0.032 %  0.013 % 4.0 29
Medivere 28.571 %   0.002 %  0.001 % 2.0 7
Thorne 82.955 %   0.004 %  0.006 % 73.0 88
Thryve 7.881 %   0.002 %  0.001 % 109.0 1383
uBiome 0.126 %   0.003 %  % 1.0 792

Symptoms Associated with Chlorobiota From Citizen Science Studies

Click on Impact for information if high or low levels are causing the impact

MagnitudeImpactSymptom

To see medical conditions associated you may be logged in

And display level must be raised above public.


This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)